Anthropic's Long-Term Benefit Trust appoints Vas Narasimhan to Board of Directors

TL;DR

Vas Narasimhan, Novartis CEO and physician-scientist, has joined Anthropic's Board via the Long-Term Benefit Trust, which now holds board majority. With 35+ years shepherding breakthrough medicines through regulated industries, Narasimhan brings expertise in scaling transformative technology responsibly. The appointment strengthens governance oversight aligned with Anthropic's public benefit mission as it grows.

• •Vas Narasimhan (Novartis CEO) appointed to Anthropic Board by Long-Term Benefit Trust
• •Trust-appointed directors now form board majority, reinforcing responsible governance structure
• •Narasimhan's pharma regulatory expertise aligns with Anthropic's responsible AI development mission

Generated with AI, which can make mistakes.